Pancreatic Cancer Research

ResearcherUniversity of LisbonActive in the last 2 years

Graça Soveral

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8487-110X; OpenAlex author ID A5016915042. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Aquaporin-3 and aquaporin-5 impact the development of pancreatic ductal adenocarcinoma spheroids. Co-author DOI 10.1002/2211-5463.70270↗
  2. The Association of Aquaporins with MAPK Signaling Pathway Unveils Potential Prognostic Biomarkers for Pancreatic Cancer: A Transcriptomics Approach. Last author DOI 10.3390/biom15040488↗
  3. Aquaporins Transcripts with Potential Prognostic Value in Pancreatic Cancer. Last author DOI 10.3390/genes14091694↗
  4. Aquaporin-3 and Aquaporin-5 Facilitate Migration and Cell-Cell Adhesion in Pancreatic Cancer by Modulating Cell Biomechanical Properties. Co-author DOI 10.3390/cells11081308↗
  5. Differential expression of aquaporin-3 and aquaporin-5 in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/jso.24605↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Inês V. da Silva · 3 shared papers, 2022–2025 · strength 0.70
  2. Jorge Paulino · 3 shared papers, 2017–2025 · strength 0.61
  3. Paula A. Lopes · 2 shared papers, 2023–2025 · strength 0.52
  4. Catarina Pimpão · 1 shared paper, 2026 · strength 0.43
  5. Filipa Mendes · 1 shared paper, 2026 · strength 0.43
  6. Patrícia M. Silva · 1 shared paper, 2022 · strength 0.17
  7. Nuno C. Santos · 1 shared paper, 2022 · strength 0.17
  8. Inês Direito · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.